Patient education: Surgical procedures for breast cancer — Mastectomy and breast conserving therapy (Beyond the Basics)
- Michael S Sabel, MD
Michael S Sabel, MD
- Associate Professor of Surgery
- University of Michigan Medical School
- Section Editor
- Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)
Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)
- Section Editor — Breast Surgery
- Associate Professor, Department of Surgery
- Yale University School of Medicine
BREAST CANCER OVERVIEW
Breast cancer is the most common female cancer in the United States. Finding and treating breast cancer in the early stages allows many women to be cured.
This article will focus on the surgical treatment of breast cancer. An introduction to breast cancer and an overview of treatment for breast cancer is also available. (See "Patient education: Breast cancer guide to diagnosis and treatment (Beyond the Basics)".)
BREAST CANCER STAGING
In addition to removing the cancer from the breast and lymph nodes, surgery also provides important information about the "stage" of the cancer. The stage of the breast cancer (TNM) is based upon the size of the tumor in the breast (T), status of lymph nodes (N), and metastatic spread to distant sites (M).
Staging is discussed in detail in a separate article. (See "Patient education: Breast cancer guide to diagnosis and treatment (Beyond the Basics)".)
FACTORS AFFECTING SURGICAL TREATMENT
Several factors must be considered when choosing the best surgical treatment for your breast cancer. You should discuss these factors with your physician as you decide which treatment is best for you.
Microscopic findings — The surgeon must determine if a breast cancer is invasive or noninvasive (in situ). (See "Patient education: Breast cancer guide to diagnosis and treatment (Beyond the Basics)", section on 'Types of breast cancer'.)
Invasive breast cancer — Invasive breast cancers usually require surgical treatment (mastectomy or breast conserving therapy) as well as treatment after surgery (called adjuvant treatment). Adjuvant treatment can include radiation as well as systemic treatment such as chemotherapy or endocrine therapy.
Noninvasive (in situ) breast cancer — Noninvasive or in situ breast cancer is divided into two types: lobular carcinoma in situ (LCIS) and ductal carcinoma in situ (DCIS).
LCIS – Women with LCIS have an increased risk of developing breast cancer in the future. However, LCIS does not require treatment. Management of LCIS is discussed separately. (See "Atypia and lobular carcinoma in situ: High risk lesions of the breast".)
DCIS – Women with DCIS require surgical treatment (mastectomy or breast conserving therapy) and may require treatment after surgery (called adjuvant treatment). Adjuvant treatment can include radiation as well as systemic treatment such as endocrine therapy. Chemotherapy is usually not necessary. (See "Ductal carcinoma in situ: Treatment and prognosis" and "Microinvasive breast carcinoma".)
Size of the breast tumor — Larger tumors are more likely to recur and usually require more aggressive treatment. Large tumors (5 cm or about the size of an egg) may require chemotherapy before surgery, which is called neoadjuvant chemotherapy. This is given in order to shrink the tumor and allow for lumpectomy. (See "General principles of neoadjuvant therapy for breast cancer".)
Tumors that invade the skin or muscle and inflammatory breast cancers also require chemotherapy, and mastectomy is usually recommended for these more advanced cancers. This is discussed in a separate article. (See "Patient education: Locally advanced and inflammatory breast cancer (Beyond the Basics)".)
Spread to the lymph nodes — Lymph nodes are usually the first place for breast cancer to spread. If a breast cancer has spread to lymph nodes, it is called node-positive; a cancer that has not spread to the lymph nodes is called node-negative. If a breast cancer has spread to the lymph nodes, it is twice as likely to have also spread elsewhere, and therefore, to recur.
However, even when cancer has spread to the lymph nodes, there is still a chance it has not spread anywhere else in the body. The goal of surgery is to remove cancer from both the breast and the lymph nodes. (See 'Management of axillary lymph nodes' below.)
Surgical removal of the tumor is usually the first step in treating early stage breast cancer. If the breast tumor is large or more advanced, treatment with chemotherapy, trastuzumab, or sometimes anti-estrogen therapy may be recommended before surgery. (See "Patient education: Locally advanced and inflammatory breast cancer (Beyond the Basics)", section on 'Treatment of locally advanced breast cancer'.)
There are two options for breast surgery:
●Mastectomy involves removing the entire breast. (See 'Mastectomy' below.)
●Breast conserving surgery removes just the cancerous area and a small amount of surrounding normal tissue (also called lumpectomy). Breast conserving surgery plus radiation therapy is referred to as breast conserving therapy, or BCT. (See 'Breast conserving therapy (BCT)' below.)
In centers that specialize in breast cancer treatment, approximately 75 percent of women with early stage breast cancer are candidates for BCT. In 25 to 50 percent of women, there are medical, cosmetic and/or social and emotional reasons for having a mastectomy rather than BCT. Survival outcomes are the same whether BCT or mastectomy is performed.
Mastectomy may be necessary because of the location of your tumor, the size or shape of your breast, findings on your imaging examination (mammogram or MRI), whether radiation may be used, or it may be your preference. (See "Mastectomy: Indications, types, and concurrent axillary lymph node management".)
Simple mastectomy — A total or simple mastectomy involves removing the entire breast without removing the axillary lymph nodes. A technique called sentinel lymph node biopsy is performed to be sure that the cancer has not spread to the lymph nodes.
Skin-sparing mastectomy — In a skin-sparing mastectomy, the nipple and areola are usually removed but the rest of the skin over the breast is preserved. This is done in conjunction with immediate reconstruction with a plastic surgeon.
Nipple sparing mastectomy and areola-sparing mastectomy — Because there is breast tissue extending to the nipple areolar complex (NAC), standard mastectomies (both simple and skin-sparing) usually involve removing the NAC. However, for certain subsets of patients, it may be safe to preserve either the entire NAC (the nipple sparing mastectomy, NSM) or remove the nipple with the breast tissue but preserve the areola (areola-sparing mastectomy, ASM). As with the skin-sparing mastectomy, these are done in conjunction with immediate reconstruction with a plastic surgeon.
Modified radical mastectomy — During a modified radical mastectomy (MRM), the breast tissue and the lymph nodes in the armpit (the axillary lymph nodes) are removed. An axillary node dissection is necessary only if the cancer has spread to the lymph nodes. (See 'Management of axillary lymph nodes' below.)
Contralateral prophylactic mastectomy — Some women undergoing mastectomy may opt to have the opposite (uninvolved) breast removed as well. This is done to reduce the risk of a subsequent new breast cancer, particularly in women at a high risk of second breast cancers (such as those with a strong family history or a known genetic mutation).
Breast reconstruction — Reconstruction of the breast is an important option for women who undergo mastectomy. You may choose to have breast reconstruction immediately after the mastectomy or at a later time. The nipples may also be reconstructed to allow the breast to appear more natural. There are several options for reconstruction, and all women planning to undergo mastectomy should see a plastic or reconstructive surgeon to discuss these options before having breast surgery. (See "Overview of breast reconstruction".)
Complications of mastectomy — Mastectomy is generally a safe surgery, although complications can occur, including bleeding, collection of fluid, wound infection, and arm problems. (See "Patient education: Lymphedema after cancer surgery (Beyond the Basics)".)
Radiation therapy after mastectomy — Radiation therapy is sometimes recommended after a mastectomy to decrease the chance of a recurrence, especially in women who have large tumors (5 cm in size or larger), have tumors close to the chest wall, or who have four or more positive lymph nodes . The benefit of radiation after mastectomy for women with fewer involved lymph nodes may be discussed but is more controversial.
More information about radiation therapy is available below. (See 'Radiation therapy' below.)
BREAST CONSERVING THERAPY (BCT)
Breast conserving therapy refers to surgical removal of the tumor and a small portion of normal surrounding breast tissue. BCT is almost always followed by radiation therapy to the remaining breast tissue. Breast conserving surgery is also called a partial mastectomy, and less accurately, a lumpectomy. A partial mastectomy is the most commonly performed BCT procedure in the United States and Canada. (See "Breast conserving therapy".)
Invasive breast cancer — Radiation therapy (RT) refers to the exposure of a tumor to high-energy x-rays in order to slow or stop its growth. Exposure to x-rays damages cells. Unlike normal cells, cancer cells cannot repair the damage caused by exposure to x-rays over several days. This prevents the cancer cells from growing further and causes them to eventually die.
RT for breast cancer is mostly given as external beam RT, meaning that the radiation beam is generated by a machine that is outside the patient. Exposure to the beam typically takes only a few seconds (similar to having an x-ray). In general, RT is given daily, five days per week, for approximately five to six weeks. Some patients may be candidates for an accelerated course of RT, which is only given to the part of the breast where the cancer was removed. This is called “accelerated partial breast irradiation”, and can be performed with either external beam RT or by placing a catheter within the space where the tumor was and delivering the radiation from the inside (“brachytherapy”).
Radiation is generally recommended for most women who have had breast conserving surgery for invasive breast cancer, even if the tumor is very small. The goal of this treatment is to kill any remaining cancer cells. Some women, such as those who are over 70 and have hormone-receptor positive cancer, may be safely treated without radiation.
In situ breast cancer — Many women with ductal carcinoma in situ (DCIS) will be advised to have radiation therapy after breast conserving surgery. This will depend on the size and grade of the DCIS, your age, and whether the DCIS is hormone receptor positive. (See "Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis" and "Ductal carcinoma in situ: Treatment and prognosis" and "Microinvasive breast carcinoma".)
Cosmetic outcomes — With modern surgical techniques, cosmetic results are good to excellent in most women after breast conserving therapy (ie, the treated and untreated breast are almost identical or there are only slight differences). The effects of BCT on the appearance of the breast take about three years to stabilize. Factors such as weight gain and the normal age-related sagging of breast tissue also affect the shape and size of the breasts.
Complications following BCT — Following breast conserving surgery or radiation, complications can sometimes occur, including bleeding, pain, infection or collection of fluid.
MASTECTOMY VERSUS BREAST CONSERVING THERAPY
Studies show that women with localized breast cancer are equally likely to survive their cancer whether they are treated with BCT or a mastectomy [1,2].
Factors to consider — Although cancer outcomes are similar, there are several factors that you should consider when trying to decide between BCT and mastectomy.
●Tumor size – Some women who have a large tumor and small breasts are advised to undergo mastectomy rather than BCT. However, chemotherapy may be given before surgery to shrink the tumor; this may allow the woman to have breast conserving surgery, if she desires it.
●Extensive DCIS – Extensive ductal carcinoma in situ (DCIS), a very early cancer, does not respond well to chemotherapy and therefore may necessitate a mastectomy in order to make sure that all the disease is removed.
●Tumor margins – After lumpectomy, it is important to have a margin of normal breast tissue around the tumor. If cancer cells are found at or near the edges of the tissue removed, additional surgery may be necessary. If a large amount of tissue has been removed and the margins are still involved, mastectomy may be recommended.
●Tumor location – Tumors that are in the center of the breast or involve the nipple or the skin, may be treated with a mastectomy or breast conserving surgery, depending upon the expected cosmetic results.
●Need for radiation – BCT involves both lumpectomy and radiation. In addition, while radiation does allow for preservation of the breast, there are both immediate and long-term side effects. (See "Radiation therapy techniques for newly diagnosed, non-metastatic breast cancer".)
●Risk reduction – Some patients will opt to have a mastectomy (often on both sides) to reduce the risk of future breast cancers. This is particularly the case in women who carry a breast cancer gene mutation or those with significant risk factors (eg, lobular carcinoma in situ or a significant family history). (See 'Contralateral prophylactic mastectomy' above.)
●Individual needs and preferences – You should discuss your preferences and concerns about preserving your breast with your doctor.
●Risk of a second breast cancer – Some women may be candidates for BCT but may be at a high risk of developing another breast cancer. These include very young women and women with a known breast cancer gene mutation. These women may consider bilateral mastectomy to not only treat the known cancer, but prevent a second cancer in the future. Women with a very strong family history of breast cancer, such as family members in every known generation (mother, grandmother, great grandmother), are still candidates for BCT, but may wish to undergo bilateral mastectomies.
Reasons to avoid BCT — Certain factors clearly favor mastectomy over BCT. These include:
●Multiple tumors – Having two or more separate tumors in different areas (quadrants) of the breast. Some patients have more than one cancer in the breast and it may not be possible to remove all of the tumors and still save the breast.
●Extensive tumor – If tumor is spread throughout the breast tissue, it will not be possible to remove the entire tumor without a mastectomy.
●Contraindication for radiation – Some women are not candidates for radiation, such as women who are pregnant, have already had radiation to the area, or with conditions that make radiation dangerous, such as lupus skin disease.
Factors that do not affect your decision — Several factors do not play a role in the choice between BCT and mastectomy:
●The spread of cancer cells to lymph nodes in the axilla
●A chance that breast cancer cells will metastasize or spread to other locations in your body
MANAGEMENT OF AXILLARY LYMPH NODES
Most women with invasive cancer will have an operation to check for cancer cells in the axillary lymph nodes. Women with ductal carcinoma in situ (DCIS) have a very small chance of having cancer cells spreading to the axillary lymph nodes. In general, sentinel lymph node biopsy (SLNB) is not recommended for women with DCIS unless a mastectomy is being performed. In that case, SLNB is done since, if invasive cancer is found in the mastectomy specimen, the surgeon cannot go back and do an SLNB procedure after a mastectomy.
Axillary lymph node dissection — This procedure involves removing most of the lymph nodes in the axilla (armpit) to examine them for cancer cells and to help prevent the spread of the cancer to distant sites (such as the lung). This operation was commonly performed for all women with invasive breast cancer in the past and is associated with complications such as pain and arm swelling (lymphedema). An axillary lymph node dissection is now usually performed only for patients when cancerous lymph nodes can be felt in the axilla or when the sentinel lymph node excision reveals multiple nodes containing cancer or a large burden of cancer cells. An axillary lymph node dissection is also recommended in women undergoing mastectomy who have cancer in their sentinel lymph node, particularly if they are not having postmastectomy radiation. (See 'Sentinel lymph node definition' below and 'Sentinel lymph node excision' below.)
Sentinel lymph node definition — The sentinel lymph node is the first lymph node that receives lymphatic drainage from the breast. The sentinel node for patients with breast cancer is usually located in the axilla, but in some patients may be near the sternum (breast bone) between the ribs (intercostal lymph nodes). In addition, there may be more than one sentinel lymph node. Most patients do not have cancer in their sentinel lymph nodes.
Sentinel lymph node excision — A sentinel lymph node excision is performed to spare patients an axillary lymph node dissection when possible. It is based upon the finding that if the sentinel node does not contain cancer cells, the likelihood that other lymph nodes in the axilla contain cancer cells is very small .
To identify the sentinel lymph node, the surgeon injects blue dye or a radioactive material, or a combination of both into the breast. The dye or radioactive material enters the lymphatic channels and flows to the sentinel lymph node, which helps the surgeon identify and remove the appropriate lymph nodes. The sentinel nodes are examined under the microscope by a pathologist.
If no cancer cells are identified in the sentinel node(s), then no further axillary surgery is needed. Today, most women with cancer in the sentinel node(s) also do not require any additional axillary surgery. However, some patients with positive sentinel lymph node(s) may be recommended to have an axillary dissection, depending on the number of involved nodes, the burden within the node, or whether they are planning on having radiation therapy. (See "Overview of sentinel lymph node biopsy in breast cancer".)
TREATMENT AFTER SURGERY
Treatment after surgery, called adjuvant treatment, is often recommended for women with invasive breast cancer. Adjuvant treatment is discussed in a separate article. (See "Patient education: Early-stage breast cancer treatment in postmenopausal women (Beyond the Basics)" and "Patient education: Early stage breast cancer treatment in premenopausal women (Beyond the Basics)".)
SURVEILLANCE AFTER INITIAL TREATMENT
After being treated for breast cancer, there is a risk that breast cancer may recur or a new breast cancer may develop. Breast cancer survivors are advised to see their surgeon and/or medical oncologist every six months for an examination. Some patients may require examinations every three months, especially within the first three years. Your doctor will advise you on the appropriate follow-up schedule for you.
All patients treated for breast cancer are advised to perform a self-breast and chest wall examination monthly. Patients who have undergone a mastectomy with reconstruction should perform an examination of the reconstructed breast. Patients treated with a mastectomy without reconstruction should examine the chest wall. The self-examination for all patients should also include checking the lymph node areas. You should promptly call your doctor or nurse if you feel a new mass, see any redness of the skin not related to radiation treatments, or if you have any questions about your self-examination.
A yearly mammogram should be performed for all women who have undergone BCT or a unilateral mastectomy. In most instances, mammography after mastectomy and breast reconstruction is usually not recommended. (See "Approach to the patient following treatment for breast cancer".)
A summary of the American Society of Clinical Oncology's recommendations for surveillance after breast cancer treatment is provided in the table (table 1).
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed on our web site (www.uptodate.com/patients). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information — UpToDate offers two types of patient education materials.
The Basics — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.
Patient education: Breast cancer (The Basics)
Patient education: Breast reconstruction after mastectomy (The Basics)
Patient education: Choosing treatment for early-stage breast cancer (The Basics)
Patient education: Ductal carcinoma in situ (DCIS) (The Basics)
Beyond the Basics — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.
Patient education: Breast cancer guide to diagnosis and treatment (Beyond the Basics)
Patient education: Lymphedema after cancer surgery (Beyond the Basics)
Patient education: Locally advanced and inflammatory breast cancer (Beyond the Basics)
Patient education: Early-stage breast cancer treatment in postmenopausal women (Beyond the Basics)
Patient education: Early stage breast cancer treatment in premenopausal women (Beyond the Basics)
Professional level information — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.
Professional Level Information:
Overview of the treatment of newly diagnosed, non-metastatic breast cancer
Atypia and lobular carcinoma in situ: High risk lesions of the breast
Breast conserving therapy
Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis
Ductal carcinoma in situ: Treatment and prognosis
Overview of breast reconstruction
Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy
Mastectomy: Indications, types, and concurrent axillary lymph node management
Microinvasive breast carcinoma
Overview of sentinel lymph node biopsy in breast cancer
Radiation therapy techniques for newly diagnosed, non-metastatic breast cancer
Approach to the patient following treatment for breast cancer
The following organizations also provide reliable health information.
●National Cancer Institute
●American Society of Clinical Oncology
●National Comprehensive Cancer Network
●American Cancer Society
●National Library of Medicine
●Susan G. Komen Breast Cancer Foundation
Patient support — There are a number of online forums where patients can find information and support from other people with similar conditions.
- Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366:2087.
- Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995; 333:1444.
All topics are updated as new information becomes available. Our peer review process typically takes one to six weeks depending on the issue.
- BREAST CANCER OVERVIEW
- BREAST CANCER STAGING
- FACTORS AFFECTING SURGICAL TREATMENT
- SURGICAL TREATMENT
- BREAST CONSERVING THERAPY (BCT)
- MASTECTOMY VERSUS BREAST CONSERVING THERAPY
- MANAGEMENT OF AXILLARY LYMPH NODES
- TREATMENT AFTER SURGERY
- SURVEILLANCE AFTER INITIAL TREATMENT
- WHERE TO GET MORE INFORMATION